<![CDATA[Ensitrelvir Pill Reduces COVID-19 Infection Risk After Exposure]]>Ensitrelvir Pill Reduces COVID-19 Infection Risk After Exposure

A phase 3 trial of the drug ensitrelvir, known as Xocova, showed a 67% reduction in COVID-19 infection risk for people treated after exposure.

https://newsnews.ai/article/ensitrelvir-pill-prevents-covid-after-exposure

]]>https://postcall.pub/topic/fef123dd-37f0-431d-90b0-e71313199a65/ensitrelvir-pill-reduces-covid-19-infection-risk-after-exposureRSS for NodeMon, 25 May 2026 01:36:39 GMTThu, 14 May 2026 01:56:40 GMT60